Le marché des thérapies contre les dépendances était évalué à 6 691,01 millions de dollars américains en 2019 et devrait atteindre 10 735,94 millions de dollars américains d'ici 2027 ; il devrait croître à un TCAC de 6,2 % de 2020 à 2027.
La dépendance est une incapacité psychologique et physique à arrêter de consommer des drogues, de l'alcool, des opioïdes et des substances de catégorie apparentée, même si la consommation de ces substances causent divers dommages mentaux et physiques. La dépendance peut mettre la vie en danger si elle n'est pas arrêtée. Par conséquent, il existe plusieurs options telles que la pharmacothérapie et la réadaptation pour mieux arrêter la dépendance. L'augmentation des dépendances chez les gens ordinaires et l'augmentation des campagnes de sensibilisation stimulent la croissance du marché des thérapies contre les dépendances. De plus, la demande croissante de R&D des organisations sous contrat devrait soutenir la croissance du marché au cours de la période de prévision. Cependant, les coûts élevés du développement de médicaments limitent la croissance du marché.
En Amérique du Nord, les États-Unis sont le pays le plus touché en raison de la pandémie de l'épidémie de COVID-19. Le pays a signalé le plus grand nombre de cas positifs au COVID-19. À travers le pays, divers centres de recherche sur les soins de santé travaillent sur la thérapeutique COVID-19. La demande de thérapies contre les dépendances est réduite en raison du verrouillage et des perturbations de la chaîne d'approvisionnement dans la région, ce qui entrave la croissance du marché des thérapies contre les dépendances.
Régions lucratives pour le marché des thérapies contre les dépendances
Aperçu du marché
La montée de la dépendance parmi la population générale stimule la croissance du marché des thérapies contre les dépendances
La toxicomanie, également appelée trouble de la toxicomanie, entraîne des conséquences néfastes et entrave le cerveau, le comportement et les processus métaboliques d'un individu, ce qui entraîne une incapacité de contrôle. En outre, l'abus de médicaments sur ordonnance devient un grave problème dans le monde entier. La dépendance aux substances abusives est responsable de la mort de millions de personnes à travers le monde. Selon le National Institute on Drug Abuse (NIDA), environ 21 millions de personnes avaient au moins une dépendance dans le monde en 2019, dont seulement 10 % ont reçu un traitement pour la même chose.
L'alcool et la toxicomanie provoquent une lourd fardeau économique pour divers pays à travers le monde. Selon le Addiction Center, aux États-Unis, la toxicomanie et l'alcoolisme coûtent à l'économie américaine environ 600 milliards de dollars par an. Selon le Global Change Data Lab, environ 350 000 personnes dans le monde meurent chaque année à cause d'une surdose de drogue. Les données suggèrent également qu'environ 1,5 % de la charge mondiale de morbidité résulte d'une consommation excessive d'alcool et de la toxicomanie illicite. Ce pourcentage dans quelques pays peut atteindre 5 %.
Selon une étude nationale menée par l'AlIMS-Delhi en association avec 10 instituts médicaux et 15 ONG en 2019, un pourcentage substantiel d'Indiens consommaient des substances psychoactives comme la drogue, le cannabis et l'alcool. Selon l'Addiction Center, ~11% de la population française a consommé du cannabis à un moment donné entre 2017 et 2017. De plus, en 2017, ~41 000 décès ont été signalés en France en raison de la consommation d'alcool. Les amphétamines et la cocaïne sont couramment consommées par la population allemande. Cependant, les rapports du Centre de toxicomanie indiquent que le nombre de personnes qui entreprennent des traitements contre la toxicomanie a augmenté ces dernières années. La prise de conscience croissante des traitements de la toxicomanie est un autre facteur susceptible de soutenir la croissance du marché des thérapies d'addition dans les années à venir.
Aperçus basés sur le type de traitement
En fonction du type de traitement, le marché des thérapies contre les dépendances est segmenté en traitement de la dépendance à la nicotine, traitement de la dépendance à l'alcool, traitement de la dépendance aux opioïdes et traitement de la dépendance à d'autres substances. Le segment du traitement de la dépendance à la nicotine détenait la plus grande part du marché en 2019, et il devrait enregistrer le TCAC le plus élevé au cours de la période de prévision. La croissance du marché du segment du traitement de la dépendance à la nicotine est attribuée à l'augmentation des politiques anti-tabac et à la prise de conscience croissante des effets secondaires de la consommation de nicotine.
Marché thérapeutique des dépendances, par type de traitement - 2019 et 2027
Aperçus basés sur le type de drogue
Sur la base du type de drogue, le marché de la thérapie des dépendances est segmenté en varénicline, bupropion, produits de remplacement de la nicotine, buprénorphine, naltrexone, disulfirame et autres. Le segment de la varénicline détenait la plus grande part de marché en 2019. Le segment des produits de remplacement de la nicotine devrait enregistrer le TCAC le plus élevé au cours de la période de prévision. La croissance du marché du segment des produits de remplacement de la nicotine peut être attribuée à l'augmentation du nombre de fumeurs et à l'augmentation des lancements de produits de remplacement de la nicotine. Par exemple, GlaxoSmithKline propose une large gamme de produits NRT tels que Nicotinell Chewing Gum, Nicotinell Compressed Lozenge et Nicotinell 24 Hour Patch.
Informations basées sur le centre de traitement
Basées sur le centre de traitement , le marché de la thérapie des dépendances est segmenté en centre de traitement ambulatoire, centre de traitement résidentiel et centre de traitement hospitalier. En 2019, le segment des centres de traitement ambulatoire détenait la plus grande part de marché. La croissance du marché pour ce segment est attribuée à la forte préférence pour les centres de traitement ambulatoires, car ces centres proposent des traitements moins coûteux avec un horaire flexible.
Perspectives stratégiques
Diverses entreprises opérant sur le marché de la thérapie des dépendances adoptent des stratégies telles que les lancements de produits, les fusions et acquisitions, les collaborations, les innovations de produits et les extensions de portefeuille de produits pour étendre leur empreinte dans le monde entier, maintenir le nom de la marque et répondre à la demande croissante des utilisateurs finaux.
Marché thérapeutique des dépendances - par type de traitement
- Traitement de la dépendance aux opioïdes
- Traitement de la dépendance à l'alcool
- Traitement de la dépendance à la nicotine
- Traitement de la dépendance à d'autres substances
Marché thérapeutique des dépendances - par type de médicament
- Buprénorphine
- Naltrexone
- Disulfiram
- Produits de remplacement de la nicotine
- Varenicline
- Autres
< li>Bupropion
Thérapeutique des dépendances Marché - par centre de traitement
- Centre de traitement hospitalier
- Centre de traitement résidentiel
- Centre de traitement ambulatoire
Dépendances Marché thérapeutique - par canal de distribution
- Pharmacies hospitalières
- Magasins médicaux
- Autres
Marché thérapeutique des dépendances - par géographie
- Amérique du Nord
- États-Unis
- Canada
- Mexique
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne
- Reste d'Europe
- Asie-Pacifique (APAC)
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Reste de l'APAC
- Moyen-Orient et Afrique (MEA)
- Afrique du Sud
- Arabie saoudite
- EAU
- Reste de la MEA
- Amérique du Sud et centrale (SCAM )
- Brésil
- Argentine
- Reste de SCAM
< li>Europe
Profils des entreprises
- Indivior PLC
- Pfizer, Inc.
- GlaxoSmithKline Plc
- Bausch Health Companies
- Cipla, Inc.
- Orexo AB
- Purdue Pharma LP
- Alvogen
- Camurus AB
- Hikma Pharmaceuticals Plc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Addiction is a psychological and physical inability to stop consuming drugs, alcohol, Opioids, and related category substances, even though those substances have various mental and physical harms. An addiction develops dependency in a person to take that substance. Addiction can be life-threatening if not stopped. So, to stop addictions, there are several options available such as drug therapy, rehabilitation; which can stop addiction in a better way.
Rising addiction among general populace and conduction of awareness campaigns are driving the growth of the market. Moreover, rising demand for R&D from contract organizations is also expected to foster market growth.
Steeping costs of drug development is expected to hamper the growth of the market. The drug industry plays a significant role in the development of medicines and management of life-threatening diseases. The process of drug discovery includes the identification of candidates, synthesis, characterization, screening & assays for therapeutic efficacy. Developing a new drug is a multibillion-dollar investment for the manufacturers.
The List of Companies - Addictions Therapeutics Market
- Cipla Ltd
- Indivior Plc
- Pfizer Inc
- Orexo Ab,
- Glaxosmithkline Plc
- Purdue Pharma L.P
- Alvogen
- Bausch Health
- Camurus Ab
- Hikma Pharmaceuticals Plc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Nov 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Nov 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Nov 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Nov 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Nov 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)